title: [Treatment of Crohn disease in adults].
abstract: Corticosteroids are an efficient treatment for active Crohn's disease. The treatment has to be undertaken with a daily intake equivalent to 1 mg/kg per day of prednisolone for a 3 to 7 week period. Immunosuppressive agents are indicated in case of corticodependency or in case of large intestinal resection. Artificial nutrition (enteral or parenteral) is proposed in corticoresistant forms, and is usually followed by an immunosuppressive therapy. Surgical management is reserved for complications, including resistance to all medical therapy. Surgical resection has to be limited in order to avoid a short bowel syndrome. Surgery should not be considered as the ideal therapy as it has been demonstrated that recurrence after surgery increases at distance. 5-aminosalycilates compounds are an alternative therapy in mild attacks. Mesalazine may reduce the recurrence and could be considered as a possible maintenance treatment.
authors: Service de gastroentérologie et de nutrition, hôpital Rothschild, Paris, France.
authors: J
authors: J
authors: Bellanger
authors: J
authors: J
authors: Cosnes
authors: J P
authors: JP
authors: Gendre
authors: L
authors: L
authors: Beaugerie
authors: M
authors: M
authors: Malafosse
authors: Y
authors: Y
authors: Le Quintrec
mesh_terms: D000328:Adult; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D004032:Diet; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy
vernacular_title: Traitement de la maladie de Crohn de l'adulte.